|
|
||||||||
1 Laboratory for Sports
Medicine, Nine
resistance-trained men consumed either a protein-carbohydrate
supplement or placebo for 1 wk in a crossover design separated by 7 days. The last 3 days of each treatment, subjects performed resistance
exercise. The supplement was consumed 2 h before and immediately after
the workout, and blood was obtained before and after exercise (0, 15, 30, 45, and 60 min postexercise). Lactate, growth hormone, and
testosterone were significantly (P
testosterone; growth hormone; insulin; insulin-like growth
factor-I; protein; carbohydrate; anabolic; weight training
to enhance the development of muscular
strength and size with heavy-resistance training, optimal conditions
for recovery from the individual exercise training sessions are
necessary. Recovery involves the coordinated functioning
of several physiological processes that are heavily influenced by the
availability and actions of specific hormones and nutrients.
Qualitative and quantitative changes in skeletal muscle contractile
proteins are all supported and signaled by a host of systematic trophic
influences from hormones to nutrient availability (47, 49, 50, 52).
Clearly, heavy-resistance exercise disrupts or damages certain muscle
fibers that later must undergo a remodeling repair process. Dietary
nutrients, hormones, and growth factors interact to regulate this
remodeling of skeletal muscle proteins (16).
Although a considerable amount of information exists regarding the
acute hormonal responses to a single resistance exercise protocol
(29-35), no data are available concerning the acute hormonal responses to consecutive days of heavy-resistance exercise training sessions. In addition, there is virtually no information concerning the
influence of nutrition and dietary supplementation on consecutive days
of heavy-resistance training. To our knowledge, only two studies have
examined the effects of ingesting a dietary supplement composed of
protein and carbohydrate on the hormonal responses to heavy-resistance
exercise. Chandler et al. (8) demonstrated that insulin and growth
hormone concentrations during recovery from a single heavy-resistance
training session were significantly higher and testosterone
concentrations were lower when subjects consumed a protein-carbohydrate
supplement immediately before and 2 h after the workout. Fahey et al.
(14) reported that insulin concentrations were higher at the end of
exercise when subjects consumed a protein-carbohydrate supplement 30 min before and intermittently during a 2-h weight-training session.
These studies indicate that dietary nutrients consumed before, during,
and after resistance exercise alter the typical hormonal response
patterns.
Independent of exercise, dietary energy and nutrients may influence
hormonal concentrations and thus help to mediate physiological mechanisms related to recovery from heavy-resistance exercise. An
increase in caloric intake above energy requirements enhances growth
hormone, testosterone, and insulin-like growth factor-I (IGF-I)
concentrations (17). Branched-chain amino acids (BCAAs) have been shown
to alter concentrations of growth hormone (6), insulin (15),
testosterone (7), and cortisol (37). In addition, BCAAs have been shown
to attenuate protein degradation (5, 9, 40), enhance lean body mass
(36, 45), and prevent fatigue (11). The quantity and composition of
dietary fat may also impact resting (52) and exercise-induced (42)
testosterone concentrations in healthy men. Further evidence supporting
the importance of nutrition in regulating circulating hormone
concentrations is the well-known negative effects of energy
and/or protein restriction on serum IGF-I concentrations (50).
Regulation of hormones by nutrients may be hypothesized to become
increasingly important during consecutive days of intense heavy-resistance exercise in which anabolic/catabolic turnover (e.g.,
glycogen synthesis/breakdown, protein synthesis/degradation, and
intramuscular triglyceride repletion/depletion) are
accelerated. For example, inadequate carbohydrate intake
during recovery may compromise glycogen resynthesis and impair
performance (4). Protein intake at the level of the recommended daily
allowance (RDA) in weight lifters may result in a negative nitrogen
balance (37, 49) and thus potentially compromise gains in muscular size
and strength. Thus optimizing nutrition during the recovery period
between exercise training sessions may lead to a more favorable nitrogen balance and glycogen levels between training sessions.
Dietary nutrients have the ability to alter circulating hormones and
thus influence the effectiveness of the exercise stimulus to elicit
training adaptations. However, our understanding of these complex
interactions is incomplete, especially related to heavy-resistance
exercise in which several other aspects of program design (e.g.,
intensity and duration, rest periods, muscle mass involvement) and
individual characteristics (e.g., age, gender, training status) also
contribute to the exercise-induced hormonal responses (29). The intent
of this investigation was to characterize the acute hormonal responses
to heavy-resistance exercise and to examine how dietary alterations
impact the anabolic milieu in the circulation. We hypothesized that
ingesting a protein-carbohydrate supplement before and after resistance
exercise would enhance anabolic hormonal responses (insulin, growth
hormone, and IGF-I) and possibly reduce the acute catabolic response to
intense resistance exercise. Thus the primary purpose of this
investigation was to examine the influence of a high-calorie liquid
carbohydrate-protein supplement rich in BCAAs on the acute hormonal
responses to heavy-resistance exercise. In addition, a secondary
purpose was to examine these hormonal response patterns over multiple
days.
Subjects.
Nine healthy resistance-trained men volunteered to participate in this
investigation. The physical characteristics of the subjects were the
following: age, 21.3 ± 1.2 (SD); height, 181.6 ± 2.7 cm; body
mass, 85.3 ± 12.9 kg; and body fat, 14.2 ± 4.9%. All subjects
were informed as to the possible risks of the investigation before
giving their written informed consent in accordance with the
Pennsylvania State University Institutional Review Board for use of
human subjects. All subjects were currently resistance training and
were considered moderately to highly trained with 6.4 ± 2.8 yr of
resistance training experience. Subjects were training four to six
times per week. Training programs were periodized for intensity and
volume of training by using multiple sets, heavy resistance
[6-12 repetitions maximum (RM)], and varied rest
periods (1-4 min). An important point to note was that none of the
subjects were performing any high-intensity aerobic endurance training or other strenuous activities outside of their resistance training workouts (35). Thus the subjects in this study were homogenous with
regard to their "training status." Subjects were not taking any
nutritional supplements, nor did any of the subjects report the use of
anabolic drugs. Medical screening indicated that none of the subjects
had any orthopedic, endocrine, or other medical problems that would
confound their participation in the study.
Experimental design and exercise testing.
Subjects acted as their own controls. All subjects were exposed to a
supplement treatment condition and a placebo treatment condition in a
balanced, double-blind, crossover design. The duration of each
treatment was 1 wk. Initially, subjects were randomly assigned to
receive either the supplement or placebo and then were assigned to the
remaining treatment condition after a 1-wk washout period after the
completion of the first condition. A 1-wk washout period was chosen to
allow adequate recovery between experimental training sessions and to
provide sufficient time for equilibration of metabolic and hormonal
responses to baseline conditions. Again, the subjects served as their
own controls, thus enhancing the internal validity of the study. All
subjects completed 3 consecutive days of heavy-resistance exercise on
the last 3 days of each 7-day dietary treatment condition. During the
1-wk washout period, subjects performed two resistance exercise workouts (on their own) and one workout during the initial 2 days of
each 7-day condition. Thus subjects refrained from training for a
minimum of 48 h before the first workout of each 7-day condition. The
experimental time line is illustrated in Fig.
1.
![]()
ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References
0.05) elevated immediately postexercise. The lactate response was
significantly lower during supplementation on days
2 and 3. Growth
hormone and prolactin responses on day
1 were significantly higher during supplementation.
After exercise, testosterone declined below resting values during
supplementation. Cortisol decreased immediately postexercise on
day 1; the response was diminished on
days 2 and 3. Glucose and insulin were
significantly elevated by 30 min during supplementation and remained
stable during placebo. Insulin-like growth factor-I was higher during
supplementatiom on days 2 and 3. These data indicate that
protein-carbohydrate supplementation before and after training can
alter the metabolic and hormonal responses to consecutive days of
heavy-resistance exercise.
![]()
INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References
![]()
METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References

View larger version (20K):
[in a new window]
Fig. 1.
Experimental time line. Subjects consumed either a
high-calorie protein-carbohydrate supplement or placebo for 1 wk
(days 1-7). After a 1-wk
washout period (days 9-15),
subjects were assigned the opposite condition for another week
(days 16-22). A
heavy-resistance exercise workout (WO) was performed the last 3 days of
each 1-wk supplement period. Internal time line for 1 experimental day
is shown for day 6. Subjects consumed
the supplement 120 min before (2 h pre-ex) and immediately after
exercise. Blood samples were obtained preexercise (Pre) and at 0, 15, 30, 45, and 60 min postexercise. A, anthropometric measurements; S,
supplementation days.
Nutritional protocol. During each 7-day treatment condition, subjects consumed a high-calorie liquid supplement (MassFuel, Twin Laboratories, Ronkonoma, NY) or an equivalent amount of placebo containing xylitol, microcrystalline cellulose, cocoa powder, dried cream extract, guar gum, aspartame, and natural chocolate flavor. The placebo was specifically designed to look and taste identical to the supplement while providing minimal carbohydrate, protein, and calories. The supplement was composed of 33% protein (predigested casein and albumin) and 67% carbohydrate (glucose polymers, glucose, crystalline fructose, and xylitol). One serving of the supplement also contained between 50 and 1,000% of the US RDA for all essential vitamins and minerals (Table 1). Subjects were provided with individual packets of either the placebo or supplement in powder form with written instructions to mix the contents of each packet in 16 ounces of water. Subjects consumed three packets throughout the day (morning, afternoon, evening) in addition to their normal dietary intake. On exercise days, subjects drank one-half of a serving 2 h before their workout and one-half of a serving after the immediate postexercise blood draw. The remaining two servings were consumed later in the evening. Written documentation and verbal verification after the study indicated compliance with the supplement protocol was 100%. Each full serving of the supplement was calculated and individually measured to provide each subject daily with 7.9 kcal/kg, 1.3 g carbohydrate/kg, and 0.7 g protein/kg. Thus the one-half servings consumed 2 h pre- and immediately postexercise provided ~4.0 kcal/kg, 0.7 g/kg, and 0.4 g protein/kg. On the basis of body mass differences between subjects, the supplement provided between 525 and 825 kcal per serving.
|
Anthropometric measurements. Body mass was measured on a Toledo electronic scale (Reliance Electronic, Worthington, OH) to the nearest 100 g at each exercise session. Circumferences and skinfold measurements were obtained during experimental familiarization and the day after each 7-day supplementation period by using standard methods (38). Skinfold measurements from seven sites (triceps, subscapular, midaxillary, chest, suprailiac, abdomen, and thigh) and circumference measurements from four sites (arm, thigh, waist, and hips) were obtained on the right side in serial fashion by the same investigator. Skinfold thickness and circumference measurements were based on the average of two trials that differed by <1.0 and 5 mm, respectively.
Blood collection and analyses.
On experimental days, subjects reported to the laboratory and sat down
quietly for 15 min. A 20-gauge 1.25-in. Teflon cannula was inserted
into an antecubital forearm vein from which blood samples were obtained
by using a stopcock and syringe set up at the following time points:
preexercise (resting) and 0, 15, 30, 45, and 60 min postexercise. The
cannula was kept patent with periodic injections of isotonic saline.
The blood was processed and centrifuged, and the resultant serum was
stored at
84°C until analyzed. Serum lactate was determined
in duplicate via a lactate analyzer (YSI model 1500 Sport Lactate
Analyzer, Yellow Springs Instruments, Yellow Springs, OH). Serum
glucose and creatine kinase (CK) activity were determined in duplicate
via spectrophotometry (Novaspec II, Pharmacia LKB Biochrom, Cambridge,
UK) and commercial assay kits (Sigma Diagnostics, St. Louis, MO).
Hemoglobin was analyzed in triplicate by using the cyanmethemoglobin
method (Sigma Diagnostics), and hematocrit was analyzed in triplicate
from whole blood via microcentrifugation and microcapillary technique.
Percent changes in plasma volume were calculated by using hemoglobin
and hematocrit values (12). Serum total testosterone, cortisol, prolactin, growth hormone, sex hormone-binding globulin (SHBG), insulin, and IGF-I were determined in duplicate by using standard RIA
procedures. Serum total testosterone, cortisol, prolactin, and
insulin were assayed by using a solid-phase
125I RIA (Diagnos-tic
Products, Los Angeles, CA) with detection limits of 0.14 nmol/l, 5.5 nmol/l, 3.7 µg/l, and 8.6 pmol/l, respectively. Human growth hormone
was measured with a double-antibody
125I liquid-phase RIA (Nichols
Institute Diagnostics, San Juan Capistrano, CA) with a detection limit
of 0.02 µg/l. SHBG was determined via an immunoradiometric assay
(Diagnostic Systems Laboratories, Webster, TX) with a sensitivity of
3.0 nmol/l. IGF-I was assayed by using an
125I double-antibody
disequilibrium technique, including an extraction that used ODS-silica
columns (INCSTAR, Stillwater, MN). The minimum detectable
amount of IGF-I for this assay is <2.0 nmol/l. Intra- and interassay
variances for all assays were <5%.
Statistical analysis.
Statistical evaluation of the data was accomplished by using a two-way
analysis of variance with repeated-measures design. The two factors
were supplement condition (protein-carbohydrate vs. placebo) and
repeated measures (pre- and postexercise blood samples over
time). When a significant
F value was achieved, a Fisher's
least significant difference post hoc test was used to locate the
pairwise differences between means. Statistical power calculations
ranged from 0.78 to 0.80. The level of significance for this
investigation was set at P
0.05.
| |
RESULTS |
|---|
|
|
|---|
Repetitions performed per set for workout days 1, 2, and 3 were 9.5 ± 0.3, 9.6 ± 0.2, and 9.8 ± 0.2 during placebo and were 9.5 ± 0.4, 9.6 ± 0.2, and 9.6 ± 0.4 during supplement, respectively. There were no significant differences in the total volume of weight lifted (weight × repetitions) or the average weight lifted (total volume/total repetitions) from day 1, day 2, and day 3 between treatment conditions. Dietary intake and anthropometric data are shown in Table 2. Dietary energy was 1,368 kcal/day higher during the week of supplementation. Protein and carbohydrate intakes were also higher during supplementation. Expressed as a percentage of total dietary energy, protein was higher and fat was lower during supplementation. Body mass was significantly higher during supplementation at each of the three exercise sessions compared with placebo. There were no significant differences in skinfold thickness or circumference measurements between treatment conditions.
|
Serum lactate, CK activity, and glucose responses are shown in Table 3. Serum lactate concentrations increased immediately postexercise and stayed elevated above baseline through 60 min postexercise. Compared with placebo, lactate concentrations were significantly lower during supplementation at several time points on days 2 and 3. Immediately postexercise on days 1 and 2 during placebo, there was a significant increase in CK activity which remained above preexercise values the entire 60 min on day 1 and 15 min postexercise on day 2. There were no significant differences between treatment conditions in CK activity. Serum glucose concentrations were significantly elevated above preexercise concentrations at 30 and 45 min postexercise on days 1 and 2 and 15 and 30 min postexercise on day 3 during supplementation, whereas glucose remained stable during placebo. Compared with placebo, supplementation resulted in significantly higher glucose concentrations at 30 and 45 min postexercise on day 2 and a significantly lower preexercise value on day 3.
|
Serum total testosterone and SHBG responses are shown in Fig. 2. Testosterone significantly increased immediately postexercise for both treatment conditions on all 3 days. After the immediate postexercise increase, total testosterone concentrations declined to below resting values on day 3 during placebo and on days 2 and 3 during supplementation. Testosterone concentrations were significantly higher during placebo at rest and 45 min postexercise on day 2 and at 30 min postexercise on day 3. There were no significant differences for any time points on days 2 and 3 compared with corresponding time points on day 1. Serum SHBG concentrations tended to increase with exercise and then decline below resting values. Compared with day 1, immediate postexercise values during supplementation were lower on days 2 and 3. Similar to total testosterone, SHBG values during placebo were significantly higher at several time points compared with those during supplementation. There were no significant differences in the free-androgen index (total testosterone/SHBG) between treatment conditions at any time point on any day (Table 4).
|
|
Serum growth hormone concentrations significantly increased immediately postexercise and returned to resting concentrations by 60 min of recovery (Fig. 3). On day 1, growth hormone concentrations at 0, 15, and 30 min postexercise were significantly higher than placebo. The growth hormone response to exercise during supplementation on day 1 was significantly higher at all time points compared with the corresponding time points on days 2 and 3. Serum prolactin concentrations significantly increased immediately postexercise on day 1 during supplementation and days 1 and 2 during placebo (Table 5). By 60 min postexercise, prolactin concentrations had returned to preexercise values. Serum cortisol concentrations significantly increased immediately after exercise on day 1 during supplementation and on days 1 and 2 during placebo (Fig. 3). The cortisol response to exercise during supplementation was significantly higher at all time points compared with the corresponding time points on days 2 and 3.
|
|
Serum insulin and IGF-I responses are shown in Fig. 4. Insulin concentrations were not different at any time point during placebo. However, insulin was significantly greater than preexercise concentrations at 30, 45, and 60 min postexercise on all 3 days during supplementation. Furthermore, the 15- and 30-min postexercise time points were significantly greater on day 3 compared with day 1 during supplementation. Serum IGF-I concentrations were not significantly elevated after exercise in either treatment condition. The values were higher at all time points during supplementation; however, only the preexercise values on days 2 and 3 were significantly greater than placebo.
|
Changes in plasma volume shifts during recovery were not significantly
different between experimental treatment conditions. On all 3 days,
plasma volume tended to decrease immediately postexercise (less than
10% decrease), increased above resting values by 15 min
postexercise (
3% to +17%), and peak ~30-45 min
postexercise intake (+13 to +22% increases) because of fluid
supplement intake. Because no significant differences were observed
between treatment conditions, we report the absolute blood values that
were not corrected for plasma volume shifts per our previous
experimental study rationale (30, 31, 33).
| |
DISCUSSION |
|---|
|
|
|---|
The primary findings of this study were that dietary intakes of protein and carbohydrate significantly affect the hormonal response patterns to a heavy-resistance exercise protocol. In addition, it was remarkable how similar the hormonal response patterns to resistance exercise were in the placebo conditions despite consecutive days of training. This study was specifically designed to examine the effects of ingesting a liquid supplement containing carbohydrate and protein on the acute metabolic and hormonal responses to 3 consecutive days of heavy-resistance exercise. Subjects served as their own controls, and the relative intensities of the workouts were designed to be similar in the respect that each set was performed with a resistance that allowed performance of 10 repetitions (i.e., each set was a 10-RM resistance). There were no significant differences between treatment conditions in the total volume of weight lifted and the average weight lifted per set on corresponding workout days. The goal of supplementing the diet was to increase dietary energy, protein, and carbohydrate intake to induce metabolic and hormonal responses that would enhance anabolic processes (e.g., glycogen resynthesis and protein synthesis) during recovery, especially during the immediate postexercise period. Indeed, calculated dietary intake over the 1-wk supplementation periods showed that this was the case. Thus any differences in the concentrations of blood variables are most likely due to these differences in the quantity and/or composition of dietary nutrients ingested. Whether the chronic effects of supplementation (i.e., 7 days in this study) were responsible for the altered hormonal responses cannot be assessed with confidence because of the acute (i.e., immediately postexercise) ingestion of the supplement.
The high-intensity nature of the resistance exercise protocol used was reflected by the high serum lactate concentrations. These lactate responses are comparable to previously reported data in our laboratory during similar heavy-resistance exercise workouts (31, 33, 35). The lactate responses were diminished on days 2 and 3 during supplementation and on day 3 during placebo despite a similar total volume and intensity of the workouts. These lower lactate responses may be due to a relative increase in the proportion of lipid as a fuel source over carbohydrate, or, alternatively, there may have been a greater conversion of lactate into glycogen during the rest periods between sets during exercise and/or the immediate postexercise period. Although we know of no information on the effects of carbohydrate ingestion after resistance exercise on lactate during recovery, it has been estimated that between 50 and 90% of the lactate formed during endurance exercise is resynthesized back to glycogen in the muscle (2, 26, 28). Other possibilities include increased clearance of lactate via gluconeogenesis in the liver or oxidation by skeletal muscle.
Testosterone concentrations increased immediately postexercise and then returned toward resting levels over the next 60 min of recovery for placebo. In contrast, testosterone fell to below resting values during supplementation. Chandler et al. (8) observed a similar phenomenon in men who consumed a liquid supplement containing both protein and carbohydrate compared with a noncaloric placebo. These data indicate that calories, in the form of carbohydrate and/or protein, have an acute attenuating effect on circulating testosterone concentrations. Although there is a general lack of information on the impact of dietary substances on testosterone, we propose two potential dietary-related factors that may explain our findings. First, percent dietary fat during supplementation was significantly lower than during the placebo condition (14 vs. 24% of total energy). In healthy active men, a diet with a low percentage of dietary fat is associated with lower testosterone concentrations (53). Second, the protein-to-carbohydrate ratio during supplementation was significantly higher than during placebo treatment condition (0.4 vs 0.3). A high protein-to-carbohydrate ratio is also associated with lower testosterone concentrations in healthy active men (52). Furthermore, switching from a high-protein diet to a low-protein diet (i.e., decreasing the protein-to-carbohydrate ratio) has been shown to significantly increase total testosterone and SHBG (1). In support of this theory, both testosterone and SHBG concentrations were lower during the supplement condition in which the protein-to-carbohydrate ratio was higher compared with placebo. The exact mechanism(s) by which the quantity and composition of dietary nutrients regulate testosterone and its binding proteins remain to be fully elucidated.
The lower testosterone values in the study by Chandler et al. (8) occurred at the same time insulin concentrations were elevated, suggesting an interaction between these two anabolic hormones. Interestingly, the same inverse pattern of response between testosterone and insulin was also observed in this study. That is, when insulin concentrations were highest, testosterone concentrations were lowest, and when insulin concentrations were lowest, testosterone concentrations peaked. In support of our data and those of others (8), it has been shown that in adult men insulin is negatively correlated with both testosterone and SHGB (41, 46). Additionally, there may have been an increase in biologically active or free testosterone despite a lower total testosterone during supplementation. An indirect measure of the biologically active testosterone, the free-androgen index (total testosterone/SHGB), was not significantly different between supplement and placebo conditions. Thus, although total testosterone was lower at some time points during the supplement condition, it is very likely that the biologically active free testosterone was not different. Finally, it is possible that there was a greater clearance of circulating testosterone or a reduction in secretion after exercise and supplementation. The relative contributions of these mechanisms to circulating testosterone during intense exercise and dietary supplementation require further investigation.
There were no differences between conditions in resting serum growth hormone concentrations; however, the postexercise growth hormone response was higher on day 1 during supplementation. The control of growth hormone synthesis and release is predominantly thought to reside at the level of the hypothalamus via regulation by growth hormone-releasing hormone and somatostatin. However, the amplitude and frequency of growth hormone-secretory pulses may be regulated by several other factors, including nutrition and exercise, as well as circulating substrates, hormones, and growth factors (24). For example, lactate and H+ have been shown to play a role in exercise-induced stimulation of growth hormone (22, 39). Thus the higher lactate response on day 1 may explain the enhanced growth hormone response on day 1 during supplementation. Fry et al. (18) demonstrated a reduction in postexercise concentrations of lactate and growth hormone after 1 wk of high-volume weight-lifting training that was similar to our data showing a diminished response of lactate and growth hormone after 3 days of intense exercise. Furthermore, the slightly lower preexercise glucose concentration during supplementation may have contributed to the greater increase in growth hormone on day 1, because high levels of glucose inhibit the exercise-induced increase in growth hormone (20). Finally, several amino acids have been shown to increase serum growth hormone concentrations, including the BCAA leucine (6). If the leucine-enriched protein-carbohydrate supplement contributed to the enhanced growth hormone response on day 1, then the growth hormone response on days 2 and 3 should have been elevated to a similar magnitude. Because this was not the case, the elevated growth hormone response on day 1 was most likely not related to the leucine content of the supplement.
As in a previous study in our laboratory (34), no significant increases in IGF-I were observed after the resistance exercise. Growth hormone has been shown to stimulate the release of IGF-I from the liver, with peak values of IGF-I occurring ~16-28 h after growth hormone stimulation (10). This delay in growth hormone-stimulated release of IGF-I corresponds nicely with the significantly greater postexercise increase in growth hormone on day 1 and the significantly greater resting IGF-I concentrations ~23 h later on day 2 during supplementation. However, a growth hormone-induced increase in IGF-I does not explain the greater IGF-I concentrations on day 3, which occurred despite no significant differences in the resting and postexercise responses of growth hormone on day 2 during supplementation. Thus another mechanism was acting in concert with growth hormone-stimulated release of IGF-I to account for the higher concentrations observed during supplementation in this study. Decreases in total energy and protein content of the diet decrease (50) and overfeeding increases (17) serum IGF-I concentrations. The higher intake of essential amino acids (primarily BCAAs) may also have contributed to the higher IGF-I during supplementation, because essential amino acids have been shown to impact serum IGF-I and nitrogen balance to a greater extent than do nonessential amino acids (50). Thus the higher caloric and protein intake combined with the stimulus of resistance exercise may have stimulated an increase in IGF-I.
As might be expected, prolactin followed a pattern of response similar to that of growth hormone. An exercise-induced increase in prolactin has been observed in previous studies (23, 27) and appears to be related to the intensity of exercise (39). Hickson et al. (27) used a similar resistance exercise protocol to that used in this investigation and observed a similar increase in prolactin. The prolactin response on day 1 during supplementation was greater than on days 2 and 3. Similar to growth hormone, prolactin has also been shown to be influenced by lactate (40). Thus the increased prolactin response on day 1 during supplementation when lactate was also higher adds further support to the theory that increases in lactate and H+ contribute to growth hormone and prolactin secretion during exercise. The physiological significance of prolactin in men is unclear. Prolactin and growth hormone share similar sequence homology and immune system activities (19) and therefore may be important factors involved in the recovery from exercise-induced muscle disruption.
The cortisol response to exercise was diminished by
day 3 compared with
day 1 for both treatment conditions. A
similar decrease in the exercise-induced cortisol response was reported
by Fry et al. (18) in elite junior weight lifters exposed to 1 wk of high-volume resistance training. This response has been attributed to
altered hypothalamic and/or pituitary function on the basis of
the fact that subjects exhibited depressed
-endorphin concentrations (18). Both
-endorphin and ACTH are cleaved from the same precursor, propiomelanocortin polypeptide, and therefore less ACTH was available to interact with the adrenal cortex, resulting in a reduced stimulus for cortisol secretion and biosynthesis. Because we did not measure either
-endorphin or ACTH, the significance of these factors in
contributing to the lower cortisol response in the present investigation is only speculative. Yet, in a study by Kraemer et al.
(32), it was shown that
-endorphin, ACTH, and cortisol response
patterns are linked in magnitude in response to a given heavy-resistance exercise protocol.
Blood CK is a well-accepted marker of skeletal muscle tissue disruption, and resistance exercise has been shown to elevate this enzyme (31). The response time between increases in CK and muscle damage probably vary with the mode and intensity of exericse. In this study, CK values were lowest before exercise on day 1, highest during recovery on day 2, and midway between these values on day 3. Kraemer et al. (31) observed a significant correlation between peak cortisol concentrations immediately after an intense resistance exercise protocol and peak CK values 24 h later. Similarly, the cortisol response to exercise was significantly higher on day 1, which corresponds with the significantly higher CK values observed on day 2 in this study. This delayed response of CK is probably attributable to the fact that cortisol has catabolic effects on muscle tissue that induce the breakdown of cellular proteins, thus liberating this specific enzyme. In this study, supplementation did not attenuate the magnitude of sarcolemma disruption, as measured by serum CK.
Serum glucose responses were variable; however, values began to rise after the immediate postexercise ingestion of the supplement, whereas glucose was more stable during placebo. The slightly lower preexercise glucose during supplementation may be an artifact of a prior surge in insulin resulting from ingestion of the supplement 2 h before exercise (i.e., "rebound hypoglycemia").
Serum insulin concentrations were lowest immediately postexercise, peaked near 45 min postexercise, and declined toward resting values at 60 min postexercise during supplementation. Remarkably, peak serum insulin concentrations at 45 min postexercise were ~500% above rest during supplementation, well above normal peaks due to pulsatility (13) and peaks due to carbohydrate ingestion alone (8). The differences in both blood glucose and insulin concentrations during recovery are primarily attributed to ingestion of the supplement immediately postexercise. The inclusion of protein and extra BCAAs with the carbohydrate in the supplement probably accounted for the large peaks in insulin as protein acts in a synergistic fashion with carbohydrate to enhance the response of insulin in the blood (8, 55). The insulin values observed in this study were similar to those reported by Chandler et al. (8) in subjects supplemented with a liquid protein-carbohydrate supplement immediately after resistance exercise. Furthermore, these large insulin responses were not attenuated over the three resistance exercise workout sessions; in fact, the insulin response was significantly greater on day 3 compared with day 1. Insulin has a positive effect on glycogen resynthesis and protein synthesis (25). Thus a peak in insulin concentration 45 min postexercise may support important events involved in the recovery process. Furthermore, because subjects consumed ~60 g carbohydrate and 30 g protein 2 h before and immediately after each workout, the availability of nutrients for glycogen resynthesis and protein synthesis would most likely not be a limiting factor. This is important because insulin has been shown to be involved in the stimulation of amino acid uptake and incorporation of proteins after exercise (3, 21).
Although muscular performance was not a primary focus of this study, it is interesting to note that there were no significant differences between treatment conditions in the total volume of weight lifted and the average weight lifted per set on corresponding workout days. Thus the extra protein and carbohydrate provided by the supplement did not enhance acute muscular performance. One of the hypothesized benefits of ingesting the supplement was to help maintain elevated muscle glycogen concentrations over consecutive days of heavy exercise. However, there are data demonstrating that lower than normal preexercise glycogen levels do not influence the rate of glycogenolysis (44) or short-term high-intensity exercise performance (48, 54) and that higher than normal glycogen levels do not offer any addtional benefits during short-term, high-intensity exercise (55). Perhaps the duration of the resistance exercise protocol used in this investigation was not long enough to deplete glycogen concentrations to a level that would impair exercise performance. Whether ingestion of the supplement over longer periods of time would provide for enhanced recovery and improved performance is unknown.
In summary, these data indicate that consuming a nutritional supplement before and immediately after heavy-resistance training workouts performed over 3 consecutive days results in different exercise-induced patterns of metabolic and hormonal variables. Specifically, consuming a protein-carbohydrate supplement before and after a resistance training session increases the concentrations of glucose, insulin, growth hormone, and IGF-I while decreasing lactate accumulation. Such responses would be predicted to enhance glycogen and protein synthesis during recovery; however, this was not determined in this investigation. These responses were observed in a group of moderately resistance-trained men and may not apply to other populations (i.e., untrained individuals, women, etc.). These data demonstrate that protein-carbohydrate supplementation before and after training may alter the metabolic and hormonal responses to consecutive days of heavy-resistance exercise.
| |
ACKNOWLEDGEMENTS |
|---|
We thank a very dedicated group of subjects who made this project possible. We are fortunate to have a great staff and graduate students in the Center for Sports Medicine and the Noll Physiological Research Center, and we thank them for their help in data collection, medical monitoring, and nutritional support.
| |
FOOTNOTES |
|---|
This study was supported in part by a grant from Twin Laboratories, Inc. (Ronkonoma, NY), and additional support was from the Robert F. and Sandra M. Leitzinger Research Fund in Sports Medicine at the Pennsylvania State University.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: W. J. Kraemer, Director, Human Performance Laboratory, Ball State University, Muncie, IN 47306. (E-mail: wkraemer{at}gw.bsu.edu).
Received 9 January 1998; accepted in final form 2 June 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Anderson, K. E.,
W. Rosner,
M. S. Khan,
M. I. New,
S. Pang,
P. S. Wissel,
and
A. Kappas.
Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man.
Life Sci.
40:
1761-1768,
1987[Medline].
2.
Astrand, P. O.,
E. Hultman,
A. Juhlin-Dannefelt,
and
G. G. Reynolds.
Disposal of lactate during and after strenuous exercise in humans.
J. Appl. Physiol.
61:
338-343,
1986
3.
Balon, T. W.,
A. Zorzano,
J. T. Treadway,
M. N. Goodman,
and
N. B. Ruderman.
Effect of insulin on protein synthesis and degradation in skeletal muscle after exercise.
Am. J. Physiol.
258 (Endocrinol. Metab. 21):
E92-E97,
1990
4.
Bergström, J.,
L. Hermansen,
E. Hultman,
and
B. Saltin.
Diet, muscle glycogen and physical performance.
Acta Physiol. Scand.
71:
140-150,
1967[Medline].
5.
Blomstrand, E.,
and
E. A. Newsholme.
Effect of branch-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle.
Acta Physiol. Scand.
146:
293-298,
1992[Medline].
6.
Bratusch-Marrain, P.,
and
W. Waldäusl.
The influence of amino acids and somatostatin on prolactin and growth hormone release in man.
Acta Endocrinol.
90:
403-408,
1979.
7.
Carli, G.,
M. Bonifazi,
L. Lodi,
C. Lupo,
G. Martelli,
and
A. Viti.
Changes in the exercise-induced hormone response to branched chain amino acid administration.
Eur. J. Appl. Physiol.
64:
372-377,
1992.
8.
Chandler, R. M.,
H. K. Byrne,
J. G. Patterson,
and
J. L. Ivy.
Dietary supplements affect the anabolic hormones after weight-training exercise.
J. Appl. Physiol.
76:
839-845,
1994
9.
Coombes, J.,
and
L. R. McNaughton.
The effects of branched-chain amino acid supplementation on indicators of muscle damage after prolonged strenuous exercise.
Med. Sci. Sports Exerc.
27:
S149,
1995.
10.
Copeland, K. C.,
L. E. Underwood,
and
J. J. Van Wyk.
Induction of immunoreactive somatomedin-C in human serum by growth hormone: dose response relationships and effect on chromotagraphic profiles.
J. Clin. Endocrinol. Metab.
50:
690-697,
1980[Medline].
11.
Davis, J. M.
Carbohydrates, branched-chain amino acids, and endurance: the central fatigue hypothesis.
Int. J. Sport Nutr.
5:
S29-S38,
1995.
12.
Dill, D. B.,
and
D. L. Costill.
Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration.
J. Appl. Physiol.
37:
247-248,
1974
13.
Engdahl, J. H.,
J. D. Veldhuis,
and
P. A. Farrell.
Altered pulsatile insulin secretion associated with endurance training.
J. Appl. Physiol.
79:
1977-1985,
1995
14.
Fahey, T. D.,
K. Hoffman,
W. Colvin,
and
G. Lauten.
The effects of intermittent liguid meal feeding on selected hormones and substrates during intense weight training.
Int. J. Sport Nutr.
3:
67-75,
1993[Medline].
15.
Ferando, A. A.,
B. D. Williams,
C. A. Stuart,
H. W. Lane,
and
R. R. Wolfe.
Oral branched-chain amino acids decrease whole-body proteolysis.
JPEN
19:
47-54,
1995[Abstract].
16.
Florini, J. R.
Hormonal control of muscle cell growth.
J. Anim. Sci.
61:
21-37,
1985.
17.
Forbes, G. B.,
M. R. Brown,
S. L. Welle,
and
L. E. Underwood.
Hormonal response to overfeeding.
Am. J. Clin. Nutr.
49:
608-611,
1989
18.
Fry, A. C.,
W. J. Kraemer,
M. H. Stone,
B. J. Warren,
J. T. Kearney,
C. M. Maresh,
C. A. Waseman,
and
S. J. Fleck.
Endocrine and performance responses to high volume training and amino acid supplementation in elite junior weightlifters.
Int. J. Sport Nutr.
3:
306-322,
1993[Medline].
19.
Gala, R. D.
Prolactin and growth hormone in the regulation of the immune system.
Proc. Soc. Exp. Biol. Med.
198:
513-527,
1991[Abstract].
20.
Galbo, H.
Endocrinolgy and metabolism in exercise.
Int. J. Sports Med.
2:
203-211,
1981.
21.
Goldberg, A. L.
Influence of insulin and contactile activity on muscle size and protein balance.
Diabetes
28:
18-24,
1979.
22.
Gordon, S. E.,
W. J. Kraemer,
N. H. Vos,
J. M. Lynch,
and
H. G. Knuttgen.
Effect of acid-base balance on the growth hormone response to acute, high-intensity cycle exercise.
J. Appl. Physiol.
76:
821-829,
1994
23.
Gray, A. B.,
R. D. Telford,
and
M. J. Weidemann.
Endocrine response to intense interval exercise.
Eur. J. Appl. Physiol.
66:
366-371,
1993.
24.
Hartman, M. L.,
J. D. Veldhuis,
and
M. O. Thorner.
Normal control of growth hormone secretion.
Horm. Res.
40:
37-47,
1993[Medline].
25.
Haymond, M. W.,
F. F. Horber,
P. De Feo,
S. E. Kahn,
and
N. Mauras.
Effect of human growth hormone and insulin-like growth factor I on whole-body leucine and estimates of protein metabolism.
Horm. Res.
40:
92-94,
1993[Medline].
26.
Hermansen, L.,
and
O. Vaage.
Lactate disappearance and glycogen synthesis in human muscle after maximal exercise.
Am. J. Physiol.
233 (Endocrinol. Metab. Gastrointest. Physiol. 2):
E422-E429,
1977
27.
Hickson, R. C.,
K. Hidaka,
C. Foster,
M. T. Falduto,
and
R. T. Chatterton, Jr.
Successive time courses of strength development and steroid hormone responses to heavy-resistance training.
J. Appl. Physiol.
76:
663-670,
1994
28.
Hultman, E. H.
Carbohydrate metabolism during hard exercise and in the recovery period after exercise.
Acta Physiol. Scand.
128:
75-82,
1986.
29.
Kraemer, W. J. Endocrine responses to resistance
exercise. Med. Sci. Sports Exerc. 20, Suppl.: S152-S157,
1988.
30.
Kraemer, W. J.,
B. A. Aguilera,
M. Terada,
R. U. Newton,
J. M. Lynch,
G. Rosendaal,
J. M. McBride,
S. E. Gordon,
and
K. Hakkinen.
Responses of IGF-I to endogenous increases in growth hormone after heavy-resistance exercise.
J. Appl. Physiol.
79:
1310-1315,
1995
31.
Kraemer, W. J.,
J. E. Dziados,
L. J. Marchitelli,
S. E. Gordon,
E. A. Harman,
R. Mello,
S. J. Fleck,
P. N. Fryman,
and
N. T. Triplett.
Effects of different heavy-resistance exercise protocols on plasma
-endorphin concentrations.
J. Appl. Physiol.
74:
450-459,
1993
32.
Kraemer, W. J.,
S. J. Fleck,
and
W. J. Evans.
Strength and power training: physiological mechanisms of adapatations.
Exerc. Sport Sci. Rev.
24:
363-397,
1996[Medline].
33.
Kraemer, W. J.,
S. E. Gordon,
S. J. Fleck,
L. J. Marchitelli,
R. Mello,
J. E. Dziados,
K. Friedl,
E. Harman,
C. Maresh,
and
A. C. Fry.
Endogenous anabolic hormonal and growth factor responses to heavy resistance exercise in males and females.
Int. J. Sports Med.
12:
228-235,
1991[Medline].
34.
Kraemer, W. J.,
L. J. Marchitelli,
S. E. Gordon,
E. Harman,
J. E. Dziados,
R. Mello,
P. Frykman,
K. McCurry,
and
S. J. Fleck.
Hormonal and growth factor responses to heavy-resistance exercise protocols.
J. Appl. Physiol.
69:
1442-1450,
1990
35.
Kraemer, W. J.,
J. Patton,
S. E. Gordon,
E. A. Harman,
M. R. Deschenes,
K. Reynolds,
R. U. Newton,
N. T. Triplett,
and
J. E. Dziados.
Compatibility of high-intensity strength and endurance training on hormonal and skeletal muscle adaptations.
J. Appl. Physiol.
78:
976-989,
1995
36.
Krieder, R. B.,
V. Miriel,
and
E. Bertun.
Amino acid supplementation and exercise performance. Analysis of the proposed ergogenic value.
Sports Med.
16:
190-209,
1993[Medline].
37.
Lemon, P. W. R.,
M. A. Tarnopolsky,
J. D. MacDougall,
and
S. A. Atkinson.
Protein requirements and muscle mass/strength changes during intensive training in novice bodybuilders.
J. Appl. Physiol.
73:
767-775,
1992
38.
Lohman, T. G.,
A. F. Roche,
and
R. Martorell.
Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books, 1988.
39.
Luger, A.,
B. Watschinger,
P. Deuster,
T. Svoboda,
M. Clodi,
and
G. P. Chrousos.
Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion.
Neuroendocrinology
56:
112-117,
1992[Medline].
40.
MacLean, D. A.,
T. E. Graham,
and
B. Saltin.
Branched-chain amino acids augment ammonia metabolism while attenuating protein breakdown during exercise.
Am. J. Physiol.
267 (Endocrinol. Metab. 30):
E1010-E1022,
1994
41.
Pasquali, R.,
F. Casimirri,
S. Cantobelli,
N. Melchionda,
A. M. Marselli Labate,
R. Fabbri,
M. Capelli,
and
L. Bortoluzzi.
Effect of obesity and body fat distribution on sex hormones and insulin in men.
Metabolism
40:
101-104,
1991[Medline].
42.
Raben, A.,
B. Kiens,
E. A. Ritchter,
L. B. Rasmussen,
B. Svenstrup,
S. Micic,
and
P. Bennett.
Serum sex hormones and endurance performance after a lacto-ovo vegetarian and a mixed diet.
Med. Sci. Sports Exerc.
24:
1290-1297,
1992[Medline].
43.
Reilly, T.
Human circadian rhythms and exercise.
Crit. Rev. Biomed. Eng.
18:
165-180,
1990[Medline].
44.
Ren, J. M.,
S. Broberg,
K. Sahlin,
and
E. Hultman.
Influence of reduced glycogen level on glycogenolysis during short-term stimulation in man.
Acta Physiol. Scand.
139:
467-474,
1990[Medline].
45.
Schena, F.,
F. Guerrini,
P. Tregnaghi,
and
B. Kayser.
Branched-chain amino acid supplementation during trekking at high altitude. The effects on loss of body mass, body composition, and muscle power.
Eur. J. Appl. Physiol.
65:
394-398,
1992.
46.
Seidell, J. C.,
P. Bjorntorp,
L. Sjostrom,
H. Kvist,
and
R. Sannerstedt.
Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels.
Metabolism
39:
897-901,
1990[Medline].
47.
Staron, R. S.,
D. L. Karapondo,
W. J. Kraemer,
A. C. Fry,
S. E. Gordon,
J. E. Falkel,
F. C. Hagerman,
and
R. S. Hikida.
Skeletal muscle adaptations during the early phase of heavy-resistance training in men and women.
J. Appl. Physiol.
76:
1247-1255,
1994
48.
Symons, D. J.,
and
I. Jacobs.
High-intensity exercise performance is not impaired by low intramuscular glycogen.
Med. Sci. Sports Exerc.
21:
550-557,
1989[Medline].
49.
Tarnopolsky, M. A.,
S. A. Atkinson,
J. D. MacDougall,
A. Chesley,
S. Philips,
and
H. P. Schwarcz.
Evaluation of protein requirements for trained strength athletes.
J. Appl. Physiol.
73:
1986-1995,
1992
50.
Thissen, J. P.,
J. M. Ketelslegers,
and
L. E. Underwood.
Nutritional regulation of the insulin-like growth factors.
Endocr. Rev.
15:
80-101,
1994[Abstract].
51.
Thuma, J. R.,
R. Gilders,
M. Verdun,
and
B. Loucks.
Circadian rhythm of cortisol confounds cortisol responses to exercise: implications for future research.
J. Appl. Physiol.
78:
1657-1664,
1995
52.
Volek, J. S.,
M. Boetes,
J. A. Bush,
T. Incledon,
and
W. J. Kraemer.
Testosterone and cortisol in relationship to dietary nutrients and resistance exercise.
J. Appl. Physiol.
82:
49-54,
1997
53.
Wilson, G. J.,
R. U. Newton,
A. J. Murphy,
and
B. J. Humphries.
The optimal training load for the development of dynamic athletic performance.
Med. Sci. Sports Exerc.
25:
1279-1286,
1993[Medline].
54.
Wooton, S. A., and C. Williams. Influence of
carbohydrate-status on performance during maximal exercise.
Int. J. Sports Med. 5, Suppl.: 126-127,
1984.
55.
Zawadzki, K. M.,
B. B. Yaspelkis III,
and
J. L. Ivy.
Carbohydrate-protein complex increases the rate of muscle glycogen storage after exercise.
J. Appl. Physiol.
72:
1854-1859,
1992
This article has been cited by other articles:
![]() |
T. L. Ballard, J. A Clapper, B. L Specker, T. L Binkley, and M. D Vukovich Effect of protein supplementation during a 6-mo strength and conditioning program on insulin-like growth factor I and markers of bone turnover in young adults Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1442 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rankin, L. P. Goldman, M. J. Puglisi, S. M. Nickols-Richardson, C. P. Earthman, and F. C. Gwazdauskas Effect of Post-Exercise Supplement Consumption on Adaptations to Resistance Training J. Am. Coll. Nutr., August 1, 2004; 23(4): 322 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. R. Karlsson, P.-A. Nilsson, J. Nilsson, A. V. Chibalin, J. R. Zierath, and E. Blomstrand Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E1 - E7. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Petitt, S. A. Arngrimsson, and K. J. Cureton Effect of resistance exercise on postprandial lipemia J Appl Physiol, February 1, 2003; 94(2): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. KAAKS and A. LUKANOVA Effects of Weight Control and Physical Activity in Cancer Prevention: Role of Endogenous Hormone Metabolism Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 268 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Hymer, W. J. Kraemer, B. C. Nindl, J. O. Marx, D. E. Benson, J. R. Welsch, S. A. Mazzetti, J. S. Volek, and D. R. Deaver Characteristics of circulating growth hormone in women after acute heavy resistance exercise Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E878 - E887. [Abstract] [Full Text] [PDF] |
||||
|
|